Advertisement
Research Summary
Research Summary
01/23/2023
Researchers examined the implementation of a restricted opioid prescribing plan for patients who experienced pain post-surgery in efforts to reduce chronic opioid use.
01/23/2023
pain management
pain management
08/31/2022
The researchers examined trends in opioid prescribing in the United States as professional organizations update their pain management guidelines to reduce opioid use.
08/31/2022
opioids
opioids
03/02/2022
In a recent study, researchers compared the efficacy of a mindfulness-based treatment vs group psychotherapy for patients with chronic pain and misusing opioids.
03/02/2022
opioid
opioid
11/08/2018
Excessive opioid prescribing is associated with higher patient-re
11/08/2018
opioid
opioid
06/15/2018
In an effort to improve access to prevention and treatment for opioid dependence, the FDA has prioritized the approval of generic versions of medication-assisted treatment options.
06/15/2018
Opioid addiction
Opioid addiction
03/29/2018
The FDA’s Psychopharmacologic Drugs Advisory Committee recently reviewed and voted on whether to recommend lofexidine, a non-opioid drug, for the management of opioid withdrawal.
03/29/2018
opioid
opioid
01/26/2018
The authors of a recent study evaluated the 6-month effectiveness of a new program in treating individuals with substance use disorders. For details about the program, read more.
01/26/2018
opioid
opioid
01/18/2018
In a recent study, researchers sough to quantify the effects of opioid prescribing patterns following surgery on the risk of dependence, overdose, or abuse.
01/18/2018
opioid
opioid
11/17/2017
Extended-release naltrexone and sublingual buprenorphine-naloxone are pharmacologically distinct interventions to prevent opioid relapse.
11/17/2017
opioid
opioid
06/09/2017
After careful consideration, the FDA has requested that a particular opioid analgesic be removed from the market.
06/09/2017